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Abstract 
AIM
To analyze liver tests before and following treatment 
with herbal Traditional Chinese Medicine (TCM) in order 
to evaluate the frequency of newly detected liver injury.
METHODS
Patients with normal values of alanine aminotransferase 
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Melchart D et al . Herbal TCM and liver injury
(ALT) as a diagnostic marker for ruling out pre-existing 
liver disease were enrolled in a prospective study of a 
safety program carried out at the First German Hospital 
of TCM from 1994 to 2015. All patients received herbal 
products, and their ALT values were reassessed 1-3 d prior 
to discharge. To verify or exclude causality for suspected 
TCM herbs, the Roussel Uclaf Causality Assessment 
Method (RUCAM) was used.
RESULTS
This report presents for the first time liver injury data 
derived from a prospective, hospital-based and large-
scale study of 21470 patients who had no liver disease 
prior to treatment with herbal TCM. Among these, ALT 
ranged from 1 × to < 5 × upper limit normal (ULN) in 
844 patients (3.93%) and suggested mild or moderate 
liver adaptive abnormalities. However, 26 patients (0.12%) 
experienced higher ALT values of ≥ 5 × ULN (300.0 
± 172.9 U/L, mean ± SD). Causality for TCM herbs 
was RUCAM-based probable in 8/26 patients, possible 
in 16/26, and excluded in 2/26 cases. Bupleuri radix 
and Scutellariae radix were the two TCM herbs most 
commonly implicated. 
CONCLUSION 
In 26 (0.12%) of 21470 patients treated with herbal TCM, 
liver injury with ALT values of ≥ 5 × ULN was found, 
which normalized shortly following treatment cessation, 
also substantiating causality.
Key words: Traditional Chinese Medicine; Herbal medicine; 
Liver injury; Roussel Uclaf Causality Assessment Method; 
Herb induced liver injury 
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Worldwide research on herbal medicine safety is 
still limited. Adverse effects are range from clinically not 
relevant to more severe ones including suspected liver 
injury. We conducted a prospective hospital-based study 
to report the number of new liver injury in patients with 
no liver disease prior to treatment with herbal Traditional 
Chinese Medicine. Liver injury was detected in 26/21470 
patients (0.12%) with alanine aminotransferase values 
of ≥ 5 × upper limit normal. The Roussel Uclaf Causality 
Assessment Method assessed the causality of suspected 
cases and showed a causality level of “possible” for the 
majority of the liver injury cases. 
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INTRODUCTION
Traditional Chinese Medicine (TCM) with the focus on 
its herbal constituents is an individual treatment option 
with growing worldwide popularity[1,2], despite still 
insufficiently documented efficacy[3] and known adverse 
reactions[4,5]. In particular, the risk of liver injury in 
patients under therapy using TCM herbs has appeared 
as a major problem for many decades[6]. This issue has 
been known at least since 1983[7] and is in line with many 
subsequent case reports and case series[8-15]. However, 
there have been attempts to downgrade the hepatotoxic 
risk of herbal TCM but such proposals were vague and 
rejected since no proof for this claim was provided[16]. 
Other problems were recognized as variables, which 
confounded establishing valid causality[17-19]. Among 
these variables were co-medication with other herbal 
products or synthetic, potentially hepatotoxic Western 
drugs, low case data quality, incomplete consideration 
of alternative causes, and questionable quality of herbal 
TCM products. Indeed, some herbal TCM products are 
confronted with problems of misidentified herbs, im-
purities, pesticides, heavy metals, or adulteration by 
Western drugs to enhance or provide efficacy[20-24].
Other challenges included the fact that not all 
publications used a sophisticated, robust causality ass-
essment method. Nevertheless, Roussel Uclaf Causality 
Assessment Method (RUCAM)[25] was successfully 
applied in many cases of suspected liver injury by TCM 
herbs[25,26], including as examples some more recent 
reports[9,27-31]. Further, there was also uncertainty as to 
whether the observed liver disease could have been 
present prior to the initiation of the TCM use rather than 
caused by the herbal TCM therapy itself. Meeting the 
objections regarding pre-existing liver disease would 
have required an analytical approach whereby a study 
protocol is prospectively applied to patients without 
any liver disease, in whom therapy with herbal TCM is 
intended and liver tests can be analyzed under such 
treatment conditions. In patients with new abnormal 
liver tests under the therapy, causality for the suspected 
herbal TCM product can easily be assessed using RUCAM. 
So far, such a systematic prospective, large-scale in-
vestigation has not been published on liver-healthy 
individuals, at least not in the scientific literature available 
in the English language.
In this report, we present for the first time liver 
injury data derived from a prospective, hospital-based 
and large-scale study of 21470 patients, who had no 
liver disease prior to treatment by herbal TCM. This 
study focused on the effect of herbal TCM use on the 
liver integrity of patients with normal liver test results 
of alanine aminotransferase (ALT), used as a diagnostic 
biomarker to exclude liver disease. Since this study 
followed a strict protocol and was conducted under 
clinical conditions, the risk of confounding variables 
appeared low and should provide valid data. 
MATERIALS AND METHODS 
Study design 
TCM study cohort: To assess to what extent herbal 
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TCM treatment leads to liver injury, we designed a 
protocol for a prospective study in consecutive patients, 
who were admitted to the Hospital for TCM in Bad 
Kötzting, Germany. Hospital admission was commonly 
arranged by patients’ general practitioners or medical 
specialists with the intention of a TCM-based therapy. 
No restrictions on admission exist for patients residing 
in Germany, as hospital costs are covered by most 
German statutory sickness funds. Treatment modalities 
including indications, choice of specific herbal TCM 
products, daily dosage, and duration of therapy are 
based on the recommendations of the Beijing University 
of Chinese Medicine (BUCM), China[32,33].
Included in the TCM study cohort were all in-
patients with normal ALT values on admission or the 
following day, who had received treatment with TCM 
herbs during their hospital stay, and were discharged 
between January 1, 1994, and December 31, 2015. 
Initial ALT results were obtained along with a routine 
blood sampling analysis. The inclusion criteria of normal 
serum ALT activities on admission ensured a lack of a 
preexisting liver disease that could later confound the 
potential diagnosis of liver injury along with herbal TCM 
treatment. For reasons of transparency, these patients 
represent the TCM study cohort. ALT was chosen as 
a specific diagnostic biomarker to clearly exclude or 
establish a liver disease[25,34]. Patients with increased 
ALT values on admission were excluded from the study. 
To ensure the good medical care of the patients, 
six German hospital physicians and eight Chinese 
physicians who trained at the University of Chinese 
Medicine in Beijing were in charge of the patients at 
the 80-bed TCM hospital[35]. Also included in the team 
was a pharmacist. On admission, hospital physicians 
provided a complete physical examination for all pa-
tients and recorded their past medical history. They 
also assessed all normal and elevated laboratory values 
and documented these together with any adverse or 
medical event during hospitalization in a standardized 
adverse event record as part of a hospital-based safety 
and quality assurance program. During the last three 
days before discharge, the occurrence of liver injury was 
tested using serum ALT as the appropriate diagnostic 
tool. 
Treatment with TCM was carried out with TCM herbs, 
given as decoctions from raw materials[36,37]. Overall 
TCM treatment may also include acupuncture, Chinese 
manual therapy, and relaxation therapy, as outlined 
previously[19,35]. Western therapies were continued 
or prescribed if necessary. Details of prescriptions, 
each single Western drug, all specific TCM treatment 
modalities, and the duration of treatment were docu-
mented systematically in the hospital files.
Herbal TCM products were obtained from China[38,39]. 
Prior to use in patients, all herbal TCM products de-
livered to the hospital underwent a comprehensive 
preclinical drug control program under the guidance of 
the Center for Drug Research of the Ludwig-Maximilian 
University Munich and other drug control centers in 
China. For herbal TCM product quality and safety 
assessment, established methods were used that in-
cluded HPLC, colored TLC photographs, and botanical 
authenticity proof[40]. This approach aimed to reduce the 
risk of possible falsification of the herbal products and 
to ensure concentrations of heavy metals, aflatoxins, 
and microbial contamination were within the allowed 
limits. Some of the herbal products were thus rejected 
for human use before being prescribed to any patient, 
mostly due to a lack of pharmaceutical quality criteria 
or detection of contaminants outside the regulatory 
requirements. All herbal TCM products were also an-
alyzed for microbial contamination[41]. 
Liver injury study cohort: The liver injury cohort 
consists of and is limited to those patients of the TCM 
study cohort who experienced liver injury in connection 
with treatment with TCM herbs. Liver injury is defined 
by an elevated serum ALT activity of at least 5 × upper 
limit normal (ULN) in patients with normal ALT values on 
admission[25]. Case data of this liver injury cohort were 
recruited by further scrutinizing the files and adverse 
event reports supplied by the hospital physicians. 
Case identification covers age, sex, diagnosis, past 
medical history, treatment with herbal TCM drugs and 
conventional drugs, a course of laboratory data, and 
any adverse or medical event during hospitalization. 
The case details were recorded and summarized in 
individual narratives as part of the patients’ hospital 
documents. 
For patients identified with newly emerging liver 
injury, the suspected herbal TCM products were an-
alyzed and closely reviewed. The aim was to highlight 
TCM medications that might be associated with an 
increased risk of liver injury. As this safety analysis 
of herbal TCM drugs was an outcome study within a 
routine quality assurance program, approval by an 
ethical review board was not requested. All patients on 
admission provided informed written consent prior to 
study enrollment.
Causality assessment using RUCAM
In line with a previous report[19] and the recommen-
dations of the Chinese Society of Hepatology (GSH)[42], 
a causality assessment of herb induced liver injury 
(HILI) for individual cases and herbal TCM products was 
achieved using RUCAM[25]. This is the most commonly 
used liver-specific, and validated tool for liver injury 
cases, and a standard form was used to extract core 
elements of RUCAM[25]. This assessment requires the 
initial evaluation of liver injury criteria and its pattern 
in each suspected case. The core elements of RUCAM 
include: The time period from the beginning until the 
cessation of herb intake in relation to disease onset 
or from the cessation of herb use to the onset of the 
liver injury; de-challenge characteristics with a course 
of ALT values after cessation or continuation of the 
herb use; risk factors such as alcohol abuse, age and 
pregnancy; co-medication with synthetic drugs or other 
Melchart D et al . Herbal TCM and liver injury
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herbs; search for alternative causes with special care 
for all hepatitis types; available information on previous 
herbal hepatotoxicity; and response to unintentional re-
exposure. RUCAM was performed for the hepatocellular 
type of injury, and scoring was independently conducted 
by three hospital physicians (Stefan Hager, Sabine 
Albrecht, Dieter Melchart). Final RUCAM scores commonly 
range from -5 to + 14 points and the resulting causality 
levels are defined as follows: ≤ 0 points, excluded 
causality; 1-2, unlikely; 3-5, possible; 6-8, probable; and 
≥ 9, highly probable[25].
RESULTS
Flowchart
The inclusion criteria of the TCM study cohort were 
strict, especially the criterion of normal ALT values on 
admission and before the initiation of the treatment 
with herbal TCM. During the study period from 1994 
to 2015, overall, 21896 patients were admitted to the 
hospital, but 426 patients of these had increased ALT 
values and were not eligible for inclusion in the study, 
which corresponds to 1.91%. Consequently, 21470 
patients fulfilled the inclusion criteria of the TCM study 
cohort and were treated with herbal TCM (Figure 
1). Among these patients of the TCM study cohort, 
ALT values remained in the normal range in 20600 
patients (95.94%) under the TCM treatment. However, 
treatment led in 733 patients (3.41%) to abnormal 
ALT values (> 1 × ULN < 2 × ULN), in 111 patients 
(0.51%) to ALT values of ≥ 2 × ULN < 5 × ULN, 
and 26 patients (0.12%) showed ALT ≥ 5 × ULN, 
representing the liver injury study group (Figure 1).
TCM study cohort 
ALT abnormalities with values in a range from 2 × 
up to 5 × ULN observed in 111 patients in the TCM 
study cohort are clearly caused by the herbal TCM 
treatment (Figure 1 and Table 1), with a preference 
of the ALT range between 2 × and 3 × ULN (Table 1). 
These small increases are commonly without clinical 
relevance and likely due to metabolic adaptation 
caused by events associated with the metabolism of 
TCM plant chemicals.
Analysis of the TCM study cohort showed that the 
age was 52.7 ± 14.0 years (mean ± SD), and females 
accounted for 71.9% (Table 2). All patients in this 
cohort suffered for about 7.8 years (median) from 
chronic disorders that led to hospital admission (Table 
2).
Chronic diseases or health conditions prevailed 
in the patients of the TCM study cohort (Table 2), 
whereby the majority experienced psychosomatic 
diseases as well as chronic pain syndromes. Additional 
diagnoses were, for example, hypertension and sleep 
disturbance. Herbal TCM decoctions were provided 
with four to five prescriptions of about 11 TCM herbs 
(ranging from a minimum of 6 to a maximum of 19 
different herbs) per prescription during the hospital 
stay. The dosage of each herb was 6-15 g/d. The total 
Treatment with herbal TCM
Treated patients (n  = 870) 
with increased ALT values 
(> ULN)
Treated patients (n  = 
20600) with normal ALT 
values
Treated patients (n  = 733) 
with increased ALT values 
(> 1 × ULN < 2 × ULN)
Treated patients 
(n  = 111) with increased 
ALT values (≥ 2 × ULN 
< 5 × ULN)
Liver injury study cohort
Patients (n  = 26) with 
increased ALT values
(≥ 5 × ULN)
Enrollment of eligible patients 
(n  = 21470)
with normal ALT values
prior to treatment initiation
TCM study cohort
Figure 1  Flow chart of increased alanine aminotransferase values of 
patients treated at the Traditional Chinese Medicine Hospital Bad Kötzting 
between 1994 and 2015. TCM: Traditional Chinese Medicine; ALT: Alanine 
aminotransferase; ULN: Upper limit normal.
Table 1  Traditional Chinese Medicine study cohort with 
elevated values of alanine aminotransferase as multiples of upper 
limit normal
ALT as multiples of the ULN Patients (n ) with ALT elevation
Total > 1 × ULN < 2 × ULN  733
  ≥ 2 × ULN < 3 × ULN   71
  ≥ 3 × ULN < 4 × ULN   32
  ≥ 4 × ULN < 5 × ULN     8
Total ≥ 2 × ULN < 5 × ULN 111
  ≥ 5 × ULN < 6 × ULN     6
  ≥ 6 × ULN < 7 × ULN     2
  ≥ 7 × ULN < 8 × ULN     4
  ≥ 8 × ULN < 9 × ULN     3
  ≥ 9 × ULN < 10 × ULN     2
  ≥ 10 × ULN     9
Total ≥ 5 × ULN   26
Total number of elevated values of 
ALT
870
ALT: Alanine aminotransferase; ULN: Upper limit normal.
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daily dosage per prescription was mean 88 ± 18 g 
(range 18-208), provided by two dosages a day.
Liver injury study cohort 
The liver injury study cohort consisting of 26 patients 
with serum ALT ≥ 5 × ULN (Table 1) merits further 
consideration (Table 2). Compared with the large TCM 
study cohort, patients in the liver injury study cohort 
were older (52.7 ± 14.0 years vs 57.6 ± 10.5 years) 
and contained a higher percentage of women (71.9% 
vs 84.6%), whereas the duration of the hospital stay 
was similar in both cohorts (Table 2). There is a long list 
of indications for herbal TCM treatment in the patients 
in the liver injury study group, along with individual TCM 
herbs that were used as medication (Table 3). For these 
patients with confirmed liver injury, details are given 
for maximum ALT values, which range from 140 U/L to 
1052 U/L (Table 3). 
TCM herbs were rarely applied as a mono-pre-
paration, but mostly as mixtures consisting of several 
herbs adding up to 35 different drugs during the 
patients’ four-week stay. The daily dosage was 95 ± 
30 g and thus slightly higher than in the TCM study 
cohort (Table 2). Among the many herbal TCM used 
by the 26 patients in the liver injury cohort, Bupleuri 
radix and Scuterllariae radix were the two TCM herbs 
most frequently implicated in liver injury, with variable 
RUCAM-based causality gradings. Most of the patients 
received one to six TCM drugs that were associated with 
potential liver injury as evidenced from the scientific 
literature, e.g., one patient (case 8) received six 
potentially hepatotoxic herbal TCM drugs during their 
hospital stay (Table 4). 
Narratives
Narratives are essential for case details including 
treatment conditions and are presented for reasons of 
transparency and possible re-evaluation by peers or 
regulatory agencies. The narratives were documented 
in the hospital case records and are provided for all 26 
patients in the liver injury study cohort (Table 5). In only 
one patient (case 8), none of the potential hepatotoxic 
TCM herbs was prescribed. Half of the patients were 
also under co-medication with synthetic drugs, initiated 
prior to admission, and only a few of these drugs are 
known for their hepatotoxic potential. The RUCAM 
analysis excluded all co-medicated drugs as the cause 
of liver injury in the cases under consideration (Table 5).
Among the liver injury study cohort, 12/26 (46%) 
of the patients experienced one or more gastro-
intestinal symptoms such as abdominal pain, diarrhea 
(6/12), nausea (4/12), vomiting (3/12), and intestinal 
colicky cramps (3/12) (Table 2). These symptoms 
are most likely the result of incipient liver injury due 
to herbal TCM and may be interpreted as a clinical 
warning signal. Following the discontinuation of herbal 
TCM treatment, the symptoms rapidly vanished and 
ALT values normalized in virtually all patients in the 
liver injury study cohort. 
RUCAM-based causality assessment and grading
For all 26 cases in the liver injury study cohort, cau-
sality for the used herbal TCM and co-medicated 
synthetic drugs used was assessed using RUCAM. 
RUCAM-based causality for TCM herbs was probable in 
8/26 patients, possible in 16/26, and excluded in 2/26 
cases. All details are presented to facilitate thorough 
information and reassessment by other groups or 
regulators (Table 6). 
Assessing causality in the 26 cases is indeed chal-
lenging, but RUCAM can handle this condition fairly 
well. All patients used a mixture of several TCM herbs 
(Table 5). The exposure conditions of the suspected 
herbs are identical, especially regarding start of use 
and discontinuation. Therefore, basic causality gradings 
should be identical, unless some herbs have a record 
of known previous liver injury, which gives two extra 
RUCAM points, as compared to other herbs without 
such records, which do not allow two extra points. 
Therefore, differences in causality grading for TCM 
herbs can be achieved considering the criteria of known 
hepatotoxicity. In the absence of such criteria, causality 
must be attributed to all the herbs together that were 
used, without the possibility of differentiating between 
the various herbs. Some patients in the liver injury 
study cohort also used conventional drugs, which were 
prescribed either before they were included in the study 
or during hospitalization. RUCAM was also applied to 
Table 2  Comparison of Traditional Chinese Medicine study cohort with liver injury study cohort
Parameter TCM study cohort Liver injury study cohort P  (difference between both cohorts)
Patients (n) 21470 26
ALT (U/L, mean ± SD) NA 300.0 ± 172.9
Females (%) 71.9    84.6 NS
Age (yr, mean ± SD) 52.7 ± 14.0 57.6 ± 10.5 NS
Chronic diseases (%) 58.9    66.6 NS
Duration of complaints (yr, median)   7.8      8.5 NS
Duration of herbal TCM treatment (d, median, range) 20 (8-77) 19.5 (7-28) NS
Total dosage of herbal TCM (g, mean, range) 88 ± 18 (18-208) 95 ± 30 (43-155) < 0.05
Hospital stay (d, mean ± SD) 26.2 ± 5.2 26.1 ± 4.0 NS
NA: Not available; NS: Not significant; ALT: Alanine aminotransferase; TCM: Traditional Chinese Medicine.
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Table 3  Indication for treatment, maximum value of alanine aminotransferase, suspected Traditional Chinese Medicine herbs and 
Roussel Uclaf Causality Assessment Method-based causality grading in liver injury cases 1-26
Cases Indication for TCM treatment Maxi-mum ALT (U/L) Suspected TCM herbs RUCAM-based causality 
Patient 1 Asthma 
Depression 
Lower back pain syndrome
  341 Bupleuri radix
Glycyrrhizae radix Scutellariae radix
Possible (score +4)
Patient 2 Posttraumatic paralysis of both 
legs 
  140 Bupleuri radix
Glycyrrhizae radix
Scutellariae radix
Possible (score +3)
Patient 3 Chronic bronchitis
Emphysema 
Sleeping disorder
  234 Bupleuri radix
Ephedrae herba
Glycyrrhizae radix
Scutellariae radix
Probable (score +7)
Patient 4 Chronic migraine   168 Bupleuri radix
Glycyrrhizae radix
Probable (score +6)
Patient 5 Post herpes zoster state
Hypertension
Diabetes mellitus
  330 Bupleuri radix
Dictamni radicis cortex
Scutellariae radix
Excluded (score -1)
Patient 6 Chronic migraine
Cervico-brachial pain syndrome
Low back pain syndrome
Diarrhoea
  530 Bombyx batryticatus (t)
Psoraleae fructus (semen)
Scutellariae radix
Possible (score +3)
Patient 7 Lumbosacral plexus syndrome
Cervicobrachial pain syndrome
  132 Bupleuri radix 
Dictamni radices cortex
Ephedrae herba
Scutellariae radix
Possible (score +5)
Patient 8 Polyneuropathy   193 Decoction; none identified suspected herb Possible (score +3)
Patient 9 Polymyalgia rheumatica 
Fibromyalgia
  162 Bupleuri radix
Scutellariae radix
Possible (score +4)
Patient 10 Chronic migraine
Tension headache
  195 Bombyx batryticatus (t) Bupleuri radix
Meliae toosendan fructus 
Scutellariae radix
Possible (score +3)
Patient 11 Difficulty of walking
Polyneuropathy 
Low back pain syndrome
  325 Glycyrrhizae radix Excluded (score -1)
Patient 12 Chronic fatigue 
Depressive episodes
Gastrointestinal symptoms
  751 Meliae toosendan fructus Probable (score +7)
Patient 13 Low back pain syndrome
Sleeping disorder
  389 Cassiae semen Possible (score +5)
Patient 14 Chronic osteomyelitis 1052 Meliae toosendan fructus Scutellariae radix Probable (score +7)
Patient 15 Chronic fatigue 
Chronic cephalgia
  290 Bupleuri radix
Meliae toosendan fructus Scutellariae radix
Possible (score +4)
Patient 16 Lichen sclerosus
Cervical spondylosis
  715 Bombyx batryticatus (t)
Bupleuri radix
Scutellariae radix
Possible (score +5)
Patient 17 Chronic migraine
Depression
  252 Bombyx batryticatus (t)
Bupleuri radix
Cassiae semen
Scutellariae radix
Probable (score +6)
Patient 18 Spondylosis cervicalis
Depression 
Migraine 
  233 Bombyx batryticatus (t)
Bupleuri radix
Scutellariae radix
Probable (score +6)
Patient 19 Carcinophobia   249 Bombyx batryticatus (t) Probable (score +6, 2011)
(2011) Tinnitus   Bupleuri radix
(2014) Allergic sensitivity syndrome   295 Ephedrae herba
Puerariae radix
Polygoni multiflora caulis
Scutellariae radix
Probable (score +7, 2014)
Patient 20 Migraine 
Lower back pain syndrome
Depressive episodes
  207 Bupleuri radix
Ephedrae herba
Glycyrrhizae radix
Polygoni cuspidate rhizoma 
Scutellariae radix
Possible (score +4)
Patient 21 Neurasthenia
Fibromyalgia
  221 Bupleuri radix
Glycyrrhizae radix
Rhei radix et rhizoma
Scutellariae radix
Possible (score+5)
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these co-medicated drugs, which may differ regarding 
their previous hepatotoxicity and their duration of use. 
However, it is unlikely that drugs may have caused 
the increases of ALT during the hospitalization since at 
the time of inclusion in the study, the ALT values were 
normal. 
DISCUSSION
This report provides liver injury data derived from 
a prospective, hospital-based and large-scale study 
of 21470 patients, who had no liver disease prior to 
treatment with TCM herbs for the first time. Clinically 
relevant liver injury with ALT ≥ 5 × ULN developed in 
26 patients (0.12%) (Figure 1 and Tables 1-5). These 
data suggest that TCM herbs carry a risk of liver injury 
in line with other reports[9,27,28,43] and concomitantly 
dismiss contrarian claims that TCM herbs lack hepa-
totoxic potency[16]. However, the surprisingly low 
frequency of liver injury caused by herbal TCM in this 
study (Figure 1) is at a variance with several reports 
implying that liver injury cases due to these herbs occur 
at a high frequency[2,9,11,17,19,27,28,43]. The rarity of liver 
injury cases found in the present investigation may be 
explained by the strict study protocol: (1) prospective 
rather than retrospective study approach; (2) valid 
exclusion of pre-existing liver disease prior to the start 
of the therapy with TCM herbs; (3) hospital-based 
treatment with specifically trained TCM physicians 
from Germany and China; (4) use of good quality TCM 
herbal products specifically ascertained by appropriate 
analyses; (5) therapy with a median of 19.5 d, avoiding 
prolonged treatment; (6) selective inclusion in the study 
only of those patients meeting the liver injury criteria 
ALT ≥ 5 × ULN; and (7) causality assessment using 
RUCAM and ascertaining ALT dechallenge following 
Patient 22 Tension headache 
Somatoform pain disorder
Polyarthritis
361 Glycyrrhizae radix
Scutellariae radix
Possible (score +3)
Patient 23 Alopecia cranialis totalis
Hashimoto-Thyroiditis
268 Bupleuri radix 
Polygoni multiflori radix
Psoraleae fructus (semen) 
Possible (score +4)
Patient 24 Chronic migraine
Depression
210 Bombyx batryticatus (t)
Bupleuri radix
Polygoni multiflori caulis
Scutellariae radix
Probable (score +6)
Patient 25 Chronic pain syndrome 359 Bupleuri radix
Scutellariae radix
Possible (score +5)
Patient 26 Somatization
Gastrointestinal symptoms
182 Bupleuri radix
Glycyrrhizae radix
Meliae toosendan fructus
Scutellariae radix
Possible (score +3)
For ALT until 2002, the normal range was ≤ 24 U/L for males and females, thereafter ≤ 35 U/L for females and ≤ 50 U/L males. Causality levels are as 
follows: ≤ 0 points, excluded causality; 1-2, unlikely; 3-5, possible; 6-8, probable; and ≥ 9, highly probable. TCM: Traditional Chinese Medicine; RUCAM: 
Roussel Uclaf Causality Assessment Method.
Table 4  Frequency of herbal Traditional Chinese Medicine use in patients with liver injury with Traditional Chinese Medicine 
herbssuspected to cause and case number correlation to Roussel Uclaf Causality Assessment Method based causality grading 
Potentially hepatotoxic TCM herbs Total herbs (n ) RUCAM-based causality 
grading: Probable Cases
RUCAM-based causality 
grading: Possible Cases
RUCAM-based causality 
grading: Excluded Cases
Bombyx batryticatus(t)   7 17, 18, 19, 24 6, 10, 16
Bupleuri radix 19 3, 4, 17, 18, 19, 24 1, 2, 7, 9, 15, 16, 17, 20
21, 23, 25, 26
  5
Cassiae semen   2 17 13
Dictamni radicis cortex   2 7   5
Ephedrae herba   4 3, 19 7, 20
Glycyrrhizae radix   9 3, 4 1, 2, 20, 21, 22, 26 11
Meliae toosendan   5 12, 14 10, 15, 26
Polygoni cuspidate rhizoma   1 23
Polygoni multiflori caulis   2 19, 24
Polygoni multiflori radix   1 23
Psoraleae fructus (semen)   1 23
Puerariae radix   1  19
Rhei radix et rhizoma   1 21
Scutellariae 
radix
20 3, 14, 17, 18, 19, 24 1, 2, 6, 7, 9, 10, 15, 16, 
20, 21, 22, 25, 26
  5
TCM: Traditional Chinese Medicine; RUCAM: Roussel Uclaf Causality Assessment Method.
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Table 5  Narratives of the cases 1-26 of the liver injury study cohort
Patients Narratives 
Case 1
male
51 yr
(1994)
Patient with asthma (ICD-9 493.9), chronic low back pain (ICD-9 724.2), and reactive depression (ICD-9 300.4) treated with TCM 
decoctions with 8 drugs for 23 d: Angelicae sinensis radix, Asari herba, Astragali radix, Atractylodis macrocephalae rhizoma, 
Bupleuri radix, Glycyrrhizae radix, Paeoniae rubrae radix, Poria (parts), Scutellariae radix. Total daily dose: 80 g. Co-medication 
theophylline, fluocortolon. No alcohol abuse. Adverse events: nausea after drinking the decoction. ALT 293 U/L. First control after 5 d: 
ALT 341 U/L. Second control 14 d after discharge: ALT 17 U/L. No hepatitis serology
RUCAM-based causality for Bupleuri radix, Glycyrrhizae radix and Scutellariae radix: Possible (score +4)
Case 2
male
73 yr
(1994)
Patient suffered from unclear paralytic symptoms in both legs after trauma (ICD-9 344). Herbal TCM treatment with 9 drugs: 
Angelicae sinensis radix, Asari herba, Astragali radix, Atractylodis macrocephalae rhizoma, Bupleuri radix, Glycyrrhizae radix, 
Paeoniae rubrae radix, Poria (Stücke), Scutellariae radix for 22 d. Total daily dose: 60 g. Co-medication: digoxine, carbochol, 
nitrofurantoin, and sulfadiazine. No alcohol abuse. No adverse event symptoms. At discharge: ALT 140 U/L. First control 3 d later: 
ALT 100 U/L. Second control 3 wk later: ALT 22 U/L. No hepatitis serology
RUCAM-based causality for Bupleuri radix, Glycyrrhizae radix, and Scutellariae radix: Possible (score +3)
Case 3
female
68 yr
1995
Patient with chronic bronchitis (ICD-9 491), emphysema (ICD-9 492), and sleeping disorder (ICD-9 780.50) was treated with herbal 
TCM decoctions (10 drugs) for 26 d: Angelicae sinensis radix, Asari herba, Astragali radix, Atractylodis macrocephalae rhizoma, 
Bupleuri radix, Ephedrae herba, Glycyrrhizae radix, Paeoniae rubrae radix, Poria (Stücke), Scutellariae radix. Total daily dose: 80 g. 
No co-medication. No alcohol abuse. No adverse event symptoms. ALT at discharge: 234 U/L. First control at 4 wk after discharge: 
ALT 7 U/L. No hepatitis serology
RUCAM-based causality for Bupleuri radix, Ephedrae herba, Glycyrrhizae radix, and Scutellariae radix: Probable (score +7)
Case 4
female
47 yr
(1996)
Patient with migraine (ICD-9 346.0) was treated for 28 d with the following herbal TCM decoctions (15 drugs): Angelicae dahuricae 
radix, Angelicae sinensis radix, Armeniacae amarum semen, Asari herba, Bupleuri radix, Codonopsis pilosulae radix, Evodiae 
fructus, Forsythiae fructus, Glycyrrhizae radix, Isatidis radix, Ligustici chuanxiong rhizoma, Ligustici rhizoma, Lonicerae flos, 
Platycodi radix, Prunellae spica. Total daily dose: 130 g. No comedication. No alcohol abuse. No adverse event symptoms. ALT at 
discharge 168 U/L. At control 4 wk later: 18 U/L; Hepatitis serology post increased ALT detection: anti-HAV (IgM/IgG) negative; 
HBs-Ag negative; anti-HBs negative; anti-HBc (IgM/IgG) negative
RUCAM-based causality for Bupleuri radix and Glycyrrhizae radix: Probable (score +6)
Case 5
male
77 yr
(1998)
Patient with post herpes zoster state (ICD-9 053.13), hypertension (ICD-9 401), diabetes mellitus (ICD-9 250) was treated for 12 d with 
11 herbal TCM decoctions: Bupleuri radix, Chebulae fructus, Dictamni radicis cortex, Gentianae macrophyllae rhizoma, Margaritifera 
usta concha (t), Moutan radicis cortex, Myristicae semen, Paeoniae rubrae radix, Rehmanniae radix, Scutellariae radix, Sophorae 
flavescentis radix. Total daily dose: 110 g. Co-medication with potentially hepatotoxic drugs: zolpidem, anti-factor 10 Xa-activity. No 
alcohol abuse. Adverse event symptoms: Fever 38.6 °C, erythema, and transient scleral jaundice. At discharge ALT of 330 U/L, at 
control 12 wk after discharge < 24 U/L. No hepatitis serology
RUCAM-based causality for Bupleuri radix, Dictamni radicis cortex, and Scutellariae radix: Excluded (score -1)
Case 6
female
60 yr
(1999)
Patient Suffered From Chronic Migraine (ICD-9 346), Cervico-Brachial Pain Syndrome Left Side (ICD-9 723.3), Lower Back Pain 
Syndrome (ICD-9 724.2), And Diarrhea (ICD-9 787.91) Without Clear Gastrointestinal Diagnosis Since 4 yr. Herbal TCM Medication 
(22 Drugs) As Decoction For 22 D: Angelicae Dahuricae Radix, Astragali Radix, Atractylodis Rhizoma, Bombyx Batryticatus (T), 
Chrysanthemi Flos, Cicadae Periostracum (T), Cinnamomi Ramulus, Citri Reticulatae Pericarpium, Codonopsis Pilosulae Radix, 
Coicis Semen, Euryales Semen, Evodiae Fructus, Ligustici Rhizome, Lycopi Herba, Moutan Radicis Cortex, Myristicae Semen, 
Pinelliae Praeparatae Rhizome, Poria (Parts), Psoraleae Fructus (Semen), Punicae Granati Pericarpium, Rehmanniae Praeparatae 
Rhizome, Scutellariae Radix, Uncariae Cum Uncis Ramulus, Viticis Fructus. Total Daily Dose: 150 G. Co-Medication With 
Potentially Hepatotoxic Drugs: Ibuprofen 800 And Piroxicam 10. Alcohol Consumption 1 Drink Beer Daily. After Treatment For 5 D, 
Improvement Of Diarrhea, And After 22 D Migraine Attack Treated With Ibuprofen. Directly After Intake Of Ibuprofen, She Noticed 
Symptoms With Stomach Pain, Nausea, Vomiting. ALT At Discharge 530 U/L, At Control 47 D Later: 14 U/L. Hepatitis Serology 
Post Increased ALT: Anti-HAV-Igg Positive; Anti-HAV-Igm Negative; Anti-Hbs Negative; Anti-Hbc Negative
RUCAM-Based Causality For Bombyx Batryticatus (T), Psoraleae Fructus (Semen), And Scutellariae Radix: Possible (Score +3)
Case 7
female
58 yr
(1999)
Patient with lumbosacral plexus syndrome (ICD-9 953.5) and cervico-brachial syndrome (ICD-9 723.3) was treated with 24 drugs for 
26 d with decoctions: Angelicae sinensis radix, Asteris radix, Bupleuri radix, Cinnamomi ramulus, Coptidis rhizoma, Dictamni radicis 
cortex, Ephedrae herba, Farfarae flos, Forsythiae fructus, Ginkgo semen, Glehniae radix, Isatidis folium, Lonicerae flos, Lumbricus 
(t), Ophiopogonis radix, Paeoniae alba radix, Paeoniae rubra radix, Perillae fructus, Pinelliae praeparatae rhizoma, Platycodi radix, 
Rehmanniae praeparatae rhizome, Rehmanniae radix, Scutellariae radix. Total daily dose 110 g. Co-medication: theophylline, vitamin 
E. No alcohol abuse. Adverse event symptoms: Diarrhea, headache, nausea, and vomiting. ALT at discharge: 35 U/L; at first control 5 
d later ALT 132 U/L, at second control 4 wk later 8 U/L. No hepatitis serology
RUCAM-based causality for Bupleuri radix, Dictamni radices cortex, Ephedrae herba, and Scutellariae radix: Possible (score +5)
Case 8
male
65 yr
(2000)
Patient with polyneuropathy (ICD-9 357.2), who was treated with 14 drugs for 22 d with Angelicae pubescentis radix, Astragali radix, 
Chaenomelis fructus, Cinnamomi ramulus, Coptidis rhizoma, Corydalis rhizoma, Lonicerae caulis, Lumbricus (t), Mori ramulus, 
Moutan radicis cortex, Paeoniae rubrae radix, Rehmanniae praeparatae rhizoma, Spatholobi caulis, and Trachelospermi caulis. Total 
daily dose 130 g. Co-medication with potential liver toxicity: allopurinol 300 mg, atorvastatin 10 mg. Alcohol consumption 3-4 drinks 
beer per day. No adverse events. Safety check after 10 d of treatment: ALT < 24 U/L; at discharge: 193 U/L; first control 16 d later: 
ALT 24 U/L RUCAM-based causality for all used TCM herbs: Possible (score +3)
Case 9
female
78 yr
2000
Patient with polymyalgia rheumatica (ICD-9 725) and fibromyalgia (ICD-9 74.1), treated with 17 drugs for 23 d with: Astragali radix, 
Bupleuri radix, Carthami flos, Cinnamomi ramulus, Coptidis rhizoma, Curcumae longae rhizoma, Cyperi rhizoma, Glehniae radix, 
Ligustri lucidi fructus, Luffae fructus retinervus, Lycopi herba, Mori ramulus, Paeoniae rubrae radix, Rehmanniae praeparatae 
rhizoma, Scutellariae radix, Sparganii tuber (rhizoma), Trachelospermi caulis. Total daily dose: 84 g. Co-medication with potential 
liver toxicity: Triamterene, diclofenac. No alcohol abuse. No adverse event symptoms. ALT at discharge 162 U/L; first control 21 d 
later: 12 U/L. Hepatitis serology post increased ALT: anti-HAV IgG positive: Anti-HAV IgM negative; HBs-antigen negative; anti-
HBs 250 U/L, anti-HBc positive
RUCAM-based causality for Bupleuri radix and Scutellariae radix: Possible (score +4)
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Case 10
female
35 yr
(2002)
Patient suffered from migraine (ICD-9 346.0) and tension headache (ICD-9 307) since 20 yr. Treatment with 20 drugs: Albiziae cortex, 
Amomi cardamomi semen, Angelicae dahuricae radix, Angelicae sinensis radix, Artemisiae argyi folium, Bombyx batryticatus (t), 
Bupleuri radix, Codonopsis pilosulae radix, Dolichoris album semen, Evodiae fructus, Ligustici rhizoma, Margaritifera usta concha 
(t), Meliae toosendan fructus, Mori ramulus, Notopterygii rhizoma seu radix, Paeoniae albae radix, Prunellae spica, Puerariae 
radix, Scutellariae radix, Tribuli fructus as decoctions. Total daily dose: 95 g. Herbal TCM treatment for 28  d. Co-medication with 
potentially hepatotoxic drug: estradiol. Occasional alcohol use. Adverse event symptoms: abdominal pain and diarrhea. ALT at 
discharge 195 U/L; at first control 10 d later ALT 56 U/L. No hepatitis serology
RUCAM-based causality for Bombyx batryticatus (t), Bupleuri radix, Meliae toosendan fructus, and Scutellariae radix: Possible (score 
+5)
Case 11
female
74 yr
(2003)
Patient with difficulty of walking (ICD-9 719.7), polyneuropathy (ICD-9 357.2), and low back pain (ICD-9 724.2). Herbal TCM 
treatment with decoctions (25 drugs): Achyranthis bidentatae radix, Albiziae cortex, Amomi cardamomi semen, Angelicae 
pubescentis radix, Angelicae sinensis radix, Astragali radix, Atractylodis macrocephalae rhizoma, Chaenomelis fructus, Coicis 
semen, Coptidis rhizoma, Corydalis rhizoma, Glycyrrhizae radix, Margaritifera usta concha (t), Mori ramulus, Moutan radicis 
cortex, Paeoniae albae radix, Paeoniae rubrae radix, Phellodendri cortex, Rehmanniae praeparatae rhizoma, Salviae miltiorrhizae 
radix, Sappan lignum, Spatholobi caulis, Trachelospermi caulis, Tribuli fructus, Ziziphi spinosae semen.Total daily dose: 150 g. Co-
medication with potentially hepatotoxic drug: candesartan 16 mg/die (regular), enalapril (rare). No alcohol abuse. No adverse event 
symptoms. Safety check after 14 d: ALT 165 U/L. At discharge: ALT 325 U/L. First control: ALT 61 U/L, Hepatitis serology post 
increased ALT: hepatitis B and C excluded; anti-HAV (IgG) positive
RUCAM-based causality for Glycyrrhizae radix: Excluded (score -1)
Case 12
female
62 yr
(2004)
Patient with chronic fatigue (ICD-10 L53), depressive episodes (ICD-10 F32.9), and gastrointestinal symptoms (ICD-10 K59.9) 
including abdominal pains and flatulence. Treatment with herbal TCM decoctions (18 drugs) for 26 d: Albiziae cortex, Amomi 
cardamomi semen, Angelicae sinensis radix, Astragali radix, Aurantii fructus, Citri sarcodactylis fructus, Codonopsis pilosulae radix, 
Coicis semen, Corydalis rhizoma, Curcumae radix, Eriocauli flos, Meliae toosendan fructus, Moutan radicis cortex, Notoginseng 
radix, Phragmitis rhizoma, Platycodi radix, Poria (parts), Schisandrae fructus. Total daily dose 96 g. Co-medication with clorazepate. 
No alcohol abuse. ALT at discharge 751 U/L. Seventeen days after cessation of herbal TCM products: ALT 148 U/L. No more 
subsequent ALT results available. Adverse event symptoms: Directly after discharge from the TCM-hospital, the patient was 
admitted at another hospital with a department of internal medicine due to deterioration of gastrointestinal symptoms. Serology: 
EBV-IgG 590 U/L, EBV-IgM negative
RUCAM-based causality for Meliae toosendan fructus: probable (score +7)
Case 13
female
57 yr
(2004)
Patient with arthralgia (ICD-10 M25.5), lower back pain syndrome (ICD-10 M54.4), and sleeping disorder (ICD-10 G 47.9) was treated 
with herbal TCM decoctions (14 drugs) for 25 d: Achyranthis bidentatae radix, Albiziae cortex, Angelicae sinensis radix, Astragali 
radix, Cassiae semen, Cinnamomi ramulus, Curcumae longae rhizoma, Gentianae macrophyllae rhizoma, Loranthi ramulus, 
Notoginseng radix, Notopterygii rhizoma seu radix, Periploca radicis cortex, Psoraleae fructus (semen), Spatholobi caulis. Total 
daily dose: 110 g. Co-medication: L-thyroxine, aminophylline. No alcohol abuse. Adverse event symptoms: abdominal pain, loss of 
appetite, and single vomiting. ALT at discharge 389 U/L; at first control 4 d later: ALT 191 U/L, and at second control 15 d later: ALT 
22 U/L. Hepatitis serology post increased ALT: anti-HAV (IgG+IgM) positive; anti-HAV IgM negative; HBs-Antigen negative; anti-
HBs positive; anti-HBc negative; HCV ab: negative
RUCAM-based causality for Cassiae semen: possible (score +5)
Case 14
Female
52 yr
(2006)
Patient with chronic osteomyelitis (ICD-10 M86.99) left leg and a six-year history after open fracture. PMH of hepatitis A 1968. 
Treatment with herbal TCM decoctions (12 drugs) for 24 d: Achyrantis bidentatae radix, Amomi cardamom semen, Chaenomelis 
fructus, Citri grandis exocarpium, Coicis semen, Corydalis rhizoma, Mangolie officinalis cortex, Meliae toosendan fructus, Paeoniae 
rubra radix, Poria (parts), Scutellariae radix, Zingiberis rhizoma. Total daily dose: 155 g. Co-medication with potential hepatotoxicity: 
use of not overdosed paracetamol (once) and ibuprofen (when needed, but presently no intake). No alcohol abuse. At day 20 after 
admission, patient showed adverse event symptoms like abdominal pain of the colic type with intestinal cramps, nausea, and 
mushier diarrhea. No ascites, no splenomegaly, no hyperbilirubinemia. ALT at discharge 1052 U/L. Three days later: 692 U/L and 35 
d later: 33 U/L. Normal hepatitis serology with exclusion of hepatitis A, B, and C
RUCAM-based causality for Meliae toosendan fructus and Scutellariae radix: Probable (score +7)
Case 15
female
43 yr
(2007)
Patient suffered from unclear post-infectious chronic fatigue (ICD-10 G93; 10 F.43) and chronic cephalgia (ICD-10 R51). Known 
history of EBV infection. Treatment with herbal TCM decoctions containing the following 23 components for 19 d: Albiziae cortex, 
Anemarrhenae rhizoma, Astragali radix, Bambusae caulis in taeniam, Bupleuri radix, Chaenomelis fructus, Cinnamomi ramulus, Citri 
reticulatae pericarpium, Curcumae longae rhizoma, Epimedii herba, Leonuri herba, Ligustri lucidi fructus, Lycii fructus, Magnoliae 
officinalis cortex, Meliae toosendan fructus, Paeoniae rubra radix, Polygalae radix, Poria (parts), Pseudostellariae radix, Pyrrosiae 
folium, Salviae miltiorrhizae radix, Scutellariae radix, Tribuli fructus. Total daily dose: 69 g. Co-medication: L-thyroxine. No alcohol 
abuse. Adverse event symptom: abdominal pain. ALT at discharge 290 U/L; 12 d later at first control: ALT 181 U/L. Second control 
24 d later: ALT 81 U/L; third control 28 d later: normal ALT values. No hepatitis serology 
RUCAM-based causality for Bupleuri radix, Meliae toosendan fructus, and Scutellariae radix: Possible (score +4)
Case 16
female
58 yr
(2007)
Patient with lichen sclerosus (ICD-10 L90.0) and cervical spondylosis (ICD-10 M47.0) was treated with herbal TCM decoctions (11 
drugs) for 25 d: Amomi cardamomi semen, Atractylodis rhizoma, Bambusae caulis in taeniam, Bombyx batryticatus (t), Bupleuri 
radix, Coicis semen, Kochiae fructus, Phellodendri cortex, Rehmanniae radix, Salviae miltiorrhizae radix, Scutellariae radix. Total 
daily dose 43 g. No co-medication. No alcohol abuse. No adverse event symptoms. ALT values at discharge normal. Continued use of 
herbal TCM at home, but at reduced daily dose of 26 g (corresponding to about 60% of the individual hospital dosage). Twenty-one 
days after hospital stay, safety check: ALT 715 U/L. Cessation of the herb use. Fifteen days after the first control: ALT 113 U/L. Again 
14 d thereafter, at a second control: ALT 44 U/L; and at a third control, ALT 23 U/L. Hepatitis serology post first increased ALT 
values: Hepatitis B and C excluded. Anti-HAV-IgG positive; Anti-HAV-IgM negative
RUCAM-based causality for Bombyx batryticatus (t), Bupleuri radix, and Scutellariae radix: Possible (score +5)
Case 17
female
48 yr
(2010)
Patient with migraine (ICD-10 G 43.0) and depression (ICD-10 F 32.0) was treated with 11 herbal TCM components as decoctions 
for 20 d: Angelicae dahuricae radix, Bambusae caulis in taeniam, Bombyx batryticatus (t), Bupleuri radix, Cassiae semen, Curcumae 
longae rhizoma, Dipsaci radix, Gentianae macrophyllae rhizoma, Scutellariae radix, Siegesbeckiae herba, Trichosanthis fructus. Total 
daily dose: 60 g. No co-medication. No alcohol, Adverse event symptom: abdominal pain. Safety control: ALT 279 U/L. Cessation 
of the herb use. Five days after cessation and at discharge: ALT 252 U/L. First control 14 d after hospital discharge: ALT 12 U/L. 
Hepatitis serology post increased ALT: Hepatitis A, B, C excluded. Anti-EBV-VCA-IgG > 100; EBV-VCA-IgM < 0.9; HBsAb 474 Units; 
HBc ab negative; HCV ab not reactive; EBV-EBNA1-Ab (IgG) > 100 Units; Anti-HAV (IgM) negative; Anti-HBc (IgM) negative
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RUCAM-based causality for Bombyx baytryticuatus (t), Bupleuri radix, Cassiae semen and Scutellariae radix: Probable (score +6)
Case 18
female
52 yr
(2010)
Patient with depression (ICD-10 F32.1), migraine (ICD-10 G43.0), spondylosis cervical (ICD-10 M47.8), and cephalgia (ICD-10 R51) 
treated with 16 drugs: Achyranthis bidentatae radix, Angelicae dahuricae radix, Bambusae caulis in taeniam, Bombyx batryticatus 
(t), Bupleuri radix, Citri reticulatae pericarpium, Coicis semen, Curcumae longae rhizoma, Magnoliae officinalis cortex, Paeoniae 
rubra radix, Polygalae radix, Poria (Stücke), Scutellariae radix, Tribuli fructus, Viticis fructus, Zingiberis rhizoma. Total daily dose: 
96g. Duration of treatment for only 7 d because of adverse event symptoms of diarrhea ad deterioration of headache. Co-medication: 
L-thyroxine. Safety check 14 d after admission: ALT 76 U/L; At first control 20 d after admission: ALT 233 U/L. At discharge: ALT 
198 U/L. Control 30 d after discharge: ALT 35 U/L. Serology post increased ALT: Anti-HAV (IgG, IgM) negative; anti-HAV (IgM) 
negative; HBs-antigen negative, Anti-HBs < 10 IU/L; Anti-HBc (IgG + IgM) negative; Anti-HCV negative
RUCAM-based causality for Bombyx batryticatus (t), Bupleuri radix, and Scutellariae radix: Probable (score +6)
Case 19
female
60 yr 
(2011)
In 2011, patient with carcinophobia (ICD-10 F45.2), allergic sensitivity (ICD-10 T78.4) and tinnitus (ICD-10 H93.1) was treated with 28 
drugs for 19 d with: Achyranthis bidentatae radix, Angelicae sinensis radix, Armeniacae amarum semen, Astragali radix, Atractylodis 
macrocephalae rhizoma, Aurantii immaturus fructus, Bambusae caulis in taeniam, Bombyx batryticatus (t), Bupleuri radix, 
Chrysanthemi flos, Cinnamomi ramulus, Curcumae longae rhizoma, Curcumae radix, Ephedrae herba, Edebouriellae radix, Ligustri 
lucidi fructus, Liquidambaris fructus, Luffae fructus retinervus, Lycii fructus, Menthae herba, Mori ramulus, Paeoniae albae radix, 
Paeoniae rubrae radix, Persicae semen, Peucedani radix, Polygoni multiflori caulis, Schisandrae fructus, Scutellariae radix. Daily drug 
dose 119 g. No co-medication. No alcohol. No adverse event symptoms. ALT at discharge 249 U/L; at first control after 3 d 123 U/L; 
at second control after 69 d 30 U/L. No hepatitis serology
RUCAM-based causality in 2011 for Bombyx batryticatus (t), Bupleuri radix, Ephedrae herba, Polygoni multiflori caulis, and 
Scutellariae radix: Probable (score +6)
63 yr
(2014)
In 2014, the patient was treated again with some of the previous herbal components as in 2011, now with 13 drugs: Atractylodis 
rhizoma; Bupleuri radix; Carthami flos; Clematidis radix; Curcumae longae rhizoma; Curcumae radix; Lycopodii herba; Mori 
ramulus; Pinelliae praeparatae rhizoma; Poria (parts); Puerariae radix; Sappan lig; Scutellariae radix. Total daily dose: 104 g. No co-
medication. No alcohol abuse known. No adverse event symptoms. Because of the previous experience, liver enzyme control already 
after 7 d: ALT 295 U/L; cessation of all herbal TCM products. Six days later ALT 182 U/L, and 3 d thereafter: ALT 86 U/L. Eleven 
days later: ALT 34 U/L. No hepatitis serology
RUCAM-based causality in 2014 for Bupleuri radix, Puerariae radix, and Scutellariae radix: Probable (score +7)
Case 20
female
53 yr
(2012)
Patient with depressive episode (ICD-10 F33.1), migraine (ICD-10 G43.1), and low back-pain (ICD-10 M54.1) was treated for 22 
d the with following 12 components: Achyranthis bidentatae radix, Angelicae dahuricae radix, Bupleuri radix, Cuscutae semen, 
Ligustici chuanxiong rhizome, Liquidambaris fructus, Lycii fructus, Rehmanniae radix, Scutellariae radix, Trachelospermi caulis, 
Tribuli fructus, Uncariae cum uncis ramulus. Total daily dose: 88 g. Additional wind-heat-mixture: Polygoni cuspidate rhizoma, 
Glycyrrhizae radix for 3 d. Wind-cold-mixture: Ephedra herba and Polygoni cuspidate rhizoma. Total daily dose: No comedication. 
No alcohol. No adverse effect symptoms. ALT at discharge 207 U/L, 22 d later at first control 30 U/L. No hepatitis serology
RUCAM-based causality for Bupleuri radix, Ephedra herba, Glycyrrhizae radix, Polygoni cuspidate rhizoma, and Scutellariae radix: 
Possible (score +4)
Case 21
female
53 yr
(2013)
Patient with neurasthenia (ICD-10 F48.0) and fibromyalgia (ICD-10 M79.7) received herbal TCM decoction for 18 d with the 
following 24 herbs: Achyranthis bidentatae radix, Astragali radix; Atractylodis rhizoma; Aurantii immaturus fructus, Bambusae 
caulis in taeniam, Bupleuri radix, Carthami flos, Citri reticulatae pericarpium, Citri sarcodactylis fructus, Curcumae longae rhizoma, 
Dipsaci radix, Glycyrrhizae radix, Inulae flos, Loranthi ramulus, Ophiopogonis radix, Paeoniae albae radix, Paeoniae rubrae radix, 
Persicae semen, Pinelliae praeparatae rhizoma, Pseudostellariae radix, Rehmanniae radix, Rhei radix et rhizoma, Scutellariae radix, 
Siegesbeckiae herba. Total daily dose: 78 g. No potentially hepatotoxic co-medication (only L-thyroxine). No alcohol. No adverse 
event symptoms. ALT at discharge 221 U/L and 41 U/L at control 14 d later. No hepatitis serology
RUCAM-based causality for Bupleuri radix, Glycyrrhizae radix, Rhei radix et rhizoma, and Scutellariae radix: Possible (score +5)
Case 22
female
52 yr
(2013)
Patient with somatoform pain disorder (ICD-10F45.0), drug induced tension headache (ICD-10 G45.2), and polyarthritis (ICD-10 
M05.9), who was treated with herbal TCM decoctions for 22 d. The following 35 herbs were applied: Achyranthis bidentatae 
radix, Anemarrhenae rhizoma, Angelicae pubescentis radix, Astragali radix, Atractylodis rhizoma, Bambusae caulis in taeniam, 
Chaenomelis fructus, Cinnamomi ramulus, Clematidis radix, Coicis semen, Coptidis rhizoma, Curcumae longae rhizoma, Cyperi 
rhizoma, Dipsaci radix, Glycyrrhizae radix, Homalomenae rhizoma, Ligustri lucidi fructus, Liquidambaris fructus, Lonicerae caulis, 
Loranthi ramulus, Luffae fructus retinervus, Magnoliae officinalis cortex, Mori ramulus, Notopterygii rhizoma seu radix, Paeoniae 
rubrae radix, Pinelliae praeparatae rhizoma, Polygalae radix, Scutellariae radix, Siegesbeckiae herba, Sinomenii caulis, Sparganii 
tuber (rhizoma), Trachelo-spermi caulis, Tribuli fructus, Trichosanthis fructus, Uncariae cum uncis ramulus. Total daily dose was 78 g. 
Co-medication with the potentially hepatotoxic drug: omega-3-acidethylester. No alcohol-abuse, Adverse event symptoms: diarrhea, 
abdominal pain, and flatulence. Hepatitis B serology negative; HBs-Ag negative, Anti-HCV negative. At discharge: ALT 361 U/L and 
15 U/L at control 90 d later
RUCAM-based causality for Glycyrrhizae radix and Scutellariae radix: Possible (score +3)
Case 23 
female
46 yr
(2014)
Patient with alopecia cranialis totalis (ICD-10 L63.0) and Hashimoto-thyroiditis (ICD-10 E06.3) was treated for 28 d with a decoction 
containing 15 TCM herbs: Achyranthis bidentatae radix, Angelicae sinensis radix, Atractylodis macrocephalae rhizoma, Bambusae 
caulis in taeniam, Bupleuri radix, Citri reticulatae pericarpium, Cuscutae semen, Ledebouriellae radix, Lycii fructus, Periploca radicis 
cortex, Polygonati rhizoma, Polygoni multiflori radix, Poria (parts), Psoraleae fructus (semen), Testudinis plastrum (t). Total daily 
dose: 72 g. Co-medication with L-thyroxine. No alcohol. Adverse event symptom: flatulence. At discharge ALT 268 U/L, with 210 
U/L on day 20 and 62 U/L on day 30
RUCAM-based causality for Bupleuri radix, Polygoni multiflori radix, and Psoraleae fructus (semen): Possible (score +4)
Case 24 
female
51 yr
(2014)
Patient with depression (ICD-10 F33.1) and migraine (ICD-10 G43.0) took for 17 d the herbal TCM decoction with the following 18 
herbs: Achyranthis bidentatae radix, Angelicae sinensis radix, Bombyx batryticatus (t), Bupleuri radix, Curcumae longae rhizoma, 
Curcumae radix, Kochiae fructus, Ligustri lucidi fructus, Lycii fructus, Mori radicis cortex, Mori ramulus, Paeoniae rubrae radix, 
Polygoni multiflori caulis, Salviae miltiorrhizae radix, Scutellariae radix, Sparganii tuber (rhizoma), Spatholobi caulis, Tribuli fructus. 
Total daily dose was 60 g. Comedication: cimicifuga, zolpidem. No alcohol. Lack of adverse event symptoms. At discharge and 
control: ALT 210 U/L and 191 U/L. At a subsequent control 19 d later, ALT 36 U/L
RUCAM-based causality for Bombyx batryticatus (t), Bupleuri radix, Polygoni multiflori caulis, and Scutellariae radix: Probable (score 
+6) 
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discontinuation of the herbal TCM therapy. Such 
excellent investigational conditions rarely exist under 
normal field conditions, where patients are evaluated in 
retrospective studies, and often provide cases of limited 
data quality[2,6,17], mostly with the lack of a robust 
causality assessment such as RUCAM[25]. Despite these 
encouraging data under hospital conditions, herbal TCM 
treatment outside a hospital setting may be associated 
with higher liver injury risks, requiring a cautionary 
statement. Consequently and to err on the side of 
caution, patients who opt for special therapy with herbal 
TCM should be informed about the low risk of liver 
injury and its clinical symptoms.
Supportive evidence of causality for TCM herbs in 
the injury cases was provided by the rapid decline of 
ALT to nearly normal values shortly following cessation 
of herbal use in 24/26 patients (Table 5), while two 
patients escaped final ALT analysis (Table 5). Causality 
is further supported by the lack of pre-existing liver 
diseases in the patients in the liver injury study cohort, 
ruling out that alternative liver diseases could compete 
with the newly emerging liver injury caused by TCM 
herbs. Finally, the causality of liver injury for various 
TCM herbs was established using the updated RUCAM 
(Table 6), as published in 2016[25]. Causality was 
excluded in two patients, whereas most cases achieved 
a possible or even a probable causality level. Using 
both, RUCAM-based causality assessment and positive 
tests of unintentional re-exposures, valid causality was 
provided for numerous TCM herbs by other published 
analyses of liver injury[9,27,28,43]. 
It appears that patients with acute liver injury due 
to TCM herbs commonly have a good prognosis and 
no transition to chronic liver injury, at least under the 
treatment conditions of a hospital, and is possibly 
attributed to the exclusion of prolonged treatment as 
described in the present study (Table 2). This favorable 
outcome is in line with a previous RUCAM-based 
study, which does not report on severe courses[27], but 
is in contrast to a retrospective study[9] and another 
analysis[28]: Both publications reported severe clinical 
courses with the risk of acute liver failure, requirement 
of liver transplant, and of death[9,28]. In more detail, 
acute liver failure was reported in 7.8%, a requirement 
for liver transplant in 0.6%, and a fatality rate in 
3.2%, but associated RUCAM-based causality gradings 
were not published in the study[9]. This was done in 
another report of 54 patients with an RUCAM-based 
causality grading of probable for herbal TCM: One 
patient had used a herbal TCM product for 60 d and 
required a liver transplantation, while another one 
died after using TCM herb for 30 d[28]. The difference 
in outcome between the present study and previous 
publications[9,28] cannot validly be explained and is 
certainly open for discussion, especially regarding the 
duration of herbal TCM exposure, which was 19.5 d in 
this study (Table 2). 
Of note, in addition to the 21470 patients, who were 
included in the TCM study cohort due to their normal 
ALT values, 472 patients corresponding to 2.3% had 
been admitted to the hospital for TCM treatment with 
increased ALT values on admission and were therefore 
not included in the TCM study cohort. If included, 
these patients may have alternative diagnoses as 
confounders, as initially increased ALT values may 
reflect already existing liver disease. Similar to the 
hospital conditions, alternative causes as confounding 
variables have been described in suspected cases of 
Case 25 
female
53 yr 
(2015)
Patient with chronic pain syndrome (ICD-10 F 45.41; G43.9) received for 3  wk  (twice daily) herbal TCM decoctions containing 
20 different herbs: Angelicae sinensis radix, Aurantii fructus, Bambusae caulis in taeniam, Bupleuri radix, Carthami flos, Citri 
sarcodactylis fructus, Curcumae longae rhizoma, Curcumae radix, Ligustici chuanxiong rhizoma, Loranthi ramulus, Lycopodii herba, 
Mori ramulus, Persicae semen, Poria (parts), Puerariae radix, Scutellariae radix, Sparganii tuber (rhizoma), Spatholobi caulis, Tribuli 
fructus, Viticis fructus. Total daily dose: 87 g. Co-medication: intermittent use of sumatriptane and the potentially hepatotoxic drug 
paracetamol. No alcohol. No adverse effect symptoms. ALT at discharge 359 U/L, at control 18 d later ALT 69 U/L. Hepatitis A and 
B were excluded serologically
RUCAM-based causality for Bupleuri radix and Scutellariae radix: Possible (score +5)
Case 26 
female
61 yr
-2015
Patient with unspecified somatization (ICD-10 F45.1), who suffered from abdominal symptoms of nausea, diarrhea, and loss of 
appetite, received herbal TCM decoction therapy for 23 d with 26 herbs: Amomi cardamomi semen, Amomi fructus, Armeniacae 
amarum semen, Atractylodis macrocephalae rhizoma, Bambusae caulis in taeniam, Bupleuri radix, Cinnamomi ramulus, Citri 
sarcodactylis fructus, Codonopsis pilosulae radix, Coicis semen, Corydalis rhizoma, Cyperi rhizoma, Forsythiae fructus, Glehniae 
radix, Glycyrrhizae radix, Ledebouriellae radix, Meliae toosendan fructus, Mori radicis cortex, Ophiopogonis radix, Paeoniae albae 
radix, Paeoniae albae radix, Peucedani radix, Pinelliae praeparatae rhizoma, Poria (parts), Scutellariae radix, Zingiberis rhizoma. 
Total daily dose: 87 g. Intermittent co-medication with the potentially hepatotoxic pantoprazole. Alcohol use with 2 drinks a day. 
During hospital stay, she experienced deterioration of her gastrointestinal symptoms. At discharge, ALT 182 U/L. Two weeks later, 
normalization of ALT (30 U/L). No hepatitis serology
RUCAM-based causality for Bupleuri radix, Glycyrrhizae radix, Meliae toosendan fructus, and Scutellariae radix: Possible (score +3)
All patients showed normal ALT values at admission and experienced liver injury under therapy with herbal TCM. Indication for TCM treatment was 
based on diagnoses according to ICD classification. Liver injury is defined as ALT > 5 × ULN. TCM herbs with known hepatotoxicity from literature 
represented in bold[8-10]. Causality for all bold TCM herbs was assessed using the updated RUCAM[25]. Causality levels are as follows: ≤ 0 points, excluded 
causality; 1-2, unlikely; 3-5, possible; 6-8, probable; and ≥ 9, highly probable[3]. ALT normal ≤ 24 U/L until 2001 for males and females, thereafter ≤ 35 
U/L for females and ≤ 50 U/L for males. ab: Antibodies; ag: Antigen; ALT: Alanine aminotransferase; CMV: Cytomegalovirus; EBV: Epstein Barr virus; 
HAV: Hepatitis A virus; HBc: Hepatitis B core; HBs: Hepatitis B surface; HBV: Hepatitis B virus; HCV: Hepatitis C virus; HEV: Hepatitis E virus; ICD: 
International Statistical Classification of Diseases and Related Health Problems; PMH: Past medical history; RUCAM: Roussel Uclaf Causality Assessment 
Method; TCM: Traditional Chinese Medicine.
Melchart D et al . Herbal TCM and liver injury
1152 October 18, 2017|Volume 9|Issue 29|WJH|www.wjgnet.com
Table 6  Causality assessment for cases 1-26 of the liver injury study cohort, using the updated Roussel Uclaf Causality Assessment 
Method[25]
RUCAM items with attribution 
of scores (SC) 
 CASES 1-26
SC 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
1 Time to onset from the 
beginning of the herb
5-90 d +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +1 +2 +2 +2 +2 +2 +2 +2
< 5 or > 90 d +1
Alternative: Time to onset 
from cessation of the herb
≤  15 d +1
2 Course of ALT after cessation 
of the herb
Decrease ≥ 50% within 8 d +3 +3 +3 +3 +1 +3
Decrease ≥ 50% within 30 d +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2
No information of continued 
drug use
0 0 0
Decrease ≥ 50% after the 30th 
day
0 0
Decrease < 50% after the 30th 
day or recurrent increase
-2
3 Risk factors
Alcohol use (current drinks/d: 
> 2 for woman, > 3 for men)
+1
Alcohol use (current drinks/d: 
≤  2 for woman, ≤  3 for men)
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0/0 0 0 0 0 0 0 0
Age ≥ 55 yr +1 +1 +1 +1 +1 +1 +1 +1 +1 +1 +1 +1 +1 +1 +1
Age < 55 yr 0 0 0 0 0 0 0 0 0 0 0 0 0
4 Concomitant drug(s)/herb(s)
None or no information 0 0 0 0 0 0 0 0 0/0 0
Concomitant drug/herb with 
incompatible time to onset
0 0 0 0 0
Concomitant drug/herb with 
compatible or suggestive time 
to onset
-1 -1 -1 -1
Concomitant drug/herb 
known as hepatotoxin and 
with compatible or suggestive 
time to onset
-2 -2 -2 -2 -2 -2 -2 -2 -2
Concomitant drug with 
evidence for its role in this 
case (positive rechallenge or 
validated test)
-3
5 Search for alternative causes 
Group I (7 causes)
HAV: Anti-HAV-IgM Ø Ø N N Ø N Ø Ø Ø Ø N N Ø Ø N N Ø/Ø Ø Ø Ø Ø Ø N Ø
HBV: Anti-HBC-IgM, HBV-
DNA
Ø Ø N N Ø N Ø Ø Ø Ø N N N N Ø Ø N N Ø/Ø Ø Ø N Ø Ø N Ø
HCV: Anti-HCV, HCV-RNA Ø Ø N Ø Ø N N Ø Ø Ø N N N N Ø Ø N N Ø/Ø Ø Ø N Ø Ø Ø Ø
HEV: Anti-HEV-IgM, anti-
HEV-IgG, HEV-RNA
Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø/Ø Ø Ø Ø Ø Ø Ø Ø
Hepatobiliary sonography/
colour Doppler sonography 
of liver vessels/endo-
sonography/CT/MRC 
Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø N Ø Ø Ø Ø Ø/Ø Ø Ø Ø Ø Ø Ø Ø
Alcoholism N N N N N N N N N N N N N N N N N N N/N N N N N N N N
Acute recent hypotension 
history (particularly if 
underlying heart disease)
N N N N N N N N N N N N N N N N N N/N N N N N N N N
Group Ⅱ (5 causes)
Complications of underlying 
disease(s) such as sepsis, 
metastatic malignancy, 
autoimmune hepatitis, chronic 
hepatitis B or C, primary 
biliary cholangitis or sclerosing 
cholangitis, genetic liver diseases
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DILI[44,45] and HILI[46] including those caused by TCM 
herbs[9,46], and dietary supplements[46-50]. 
It is likely that in the real world, some patients 
seeking therapy with TCM herbs have a pre-existing, 
initially not recognized liver disease[9]. Uncertainty exists 
as to whether pre-existing liver disease is a risk factor 
for liver injury by TCM herbs, in analogy to some chronic 
liver diseases such as non-alcoholic fatty liver disease 
or alcoholic liver disease, which are risk factors of drug-
induced liver injury (DILI) by some special drugs[51,52]. 
Our study clearly differentiated liver injury with ALT 
values of ≥ 5 × ULN from ALT abnormalities with ALT 
values of < 5 × ULN (Table 1). Those are considered 
as an adaptive phenomenon due to the metabolism 
of the chemicals provided from the herbs to the liver. 
These adaptive abnormalities are clinically not relevant. 
The present data do not allow the general clinical 
recommendations to analyze ALT before therapy with 
TCM herbs is considered, as liver injury is unpredictable. 
ALT assessment may be helpful in legal situations to 
prevent later patient claims. 
The rarity of hepatotoxic reactions together with 
normal dosages of herbal TCM used in this study 
imply idiosyncrasy as a cause rather than an intri-
nsic mechanism, which is dose-dependent and can 
be elucidated by experimental studies. However, 
pathogenetic steps leading to the dose-independent 
idiosyncratic liver injury are largely unknown due to 
lack of appropriate animal models[17]. In analogy with 
other herbs, TCM herbs including those incriminated as 
Infection suggested by PCR 
and titre change for
N N N N N N N N N N N N N N N N N N N/N N N N N N N N
CMV (anti-CMV-IgM, anti-
CMV-IgG)
EBV (anti-EBV-IgM, anti-EBV-
IgG)
Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø/Ø Ø Ø Ø Ø 
Ø
Ø Ø Ø
HSV (anti-HSV-IgM, anti-
HSV-IgG)
Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø + Ø Ø/Ø Ø Ø Ø Ø Ø Ø Ø
VZV (anti-VZV-IgM, anti-
VZV- IgG) 
Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø/Ø Ø Ø Ø Ø Ø Ø Ø
Evaluation of group I and Ⅱ Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø Ø/Ø Ø Ø Ø Ø Ø Ø
All causes - groups I and Ⅱ - 
reasonably ruled out
+2
The 7 causes of group I ruled 
out 
+1
6 or 5 causes of group I ruled 
out
0 0 0 0 0 0 0 0 0
Less than 5 causes of group I 
ruled out 
-2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 1 -2 -2 -2 -2 -2 -2
Alternative cause highly 
probable
-3
6 Previous information on 
hepatotoxicity of the herb 
Reaction labelled in the 
product characteristics
+2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2 +2/+2 +2 +2 +2 +2 +2 +2 +2
Reaction published but 
unlabelled
+1 +1
Reaction unknown 0 0 0
7 Response to unintentional 
reexposure
Doubling of ALT with the herb 
alone, provided ALT below 5 
ULN before reexposure
+3
Doubling of ALT with the herb 
already given at the time of 
first reaction
+1 +1
Increase of ALT but less than 
ULN in the same conditions as 
for the first administration
-2
Other situations 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total score for case 4 3 7 6 -1 3 5 3 4 3 -1 7 5 7 4 5 6 6  6/7 4 5 3 4 6 5 3
Total score for causality: ≤ 0/excluded; 1-2/unlikely; 3-5/possible; 6-8/probable; ≥ 9/highly probable. Considered were the items for the hepatocellular 
type of liver injury and the data of 26 patients with normal ALT values at hospital admission, who experienced elevated ALT levels > 5 × ULN after use of 
herbal TCM. In the above section 4 (part 1 of the tabula) of concomitant drug(s), the following TCM herbs and drugs were considered. In the section 5 (search 
for alternative causes in part 2 of the tabula), the symbol of (n) denotes that the obtained result was negative, whereas (Ø) indicates that assessment was 
not performed. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CT: Computed tomography; HAV: Hepatitis A virus; HBc: Hepatitis B 
core; HBV: Hepatitis B virus; HCV: Hepatitis C virus; CMV: Cytomegalovirus; EBV: Epstein Barr virus; HEV: Hepatitis E virus; HSV: Herpes simplex virus; 
MRC: Magnetic resonance cholangiography; PCR: Polymerase chain reaction; RUCAM: Roussel Uclaf Causality Assessment Method; ULN: Upper limit 
normal; VZV: Varicella zoster virus.
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causes of liver injury in the present study (Tables 3 and 
5) contain dozens of known chemicals as ingredients but 
their specific hepatotoxic potency is difficult to assess and 
remains largely unknown[28]. Another problem of most 
TCM therapy regimens is the multiplicity of herbs included 
as ingredients in herbal mixtures[19,28], such as up to 35 in 
the present study (Table 5). Multiple plant chemicals of 
many herbs may lead to an increased risk of liver injury, 
which were described at least for DILI if several drugs 
were co-administered[53], and for herb-herb interactions 
or herb-drug interactions, if concomitantly used with 
Western drugs[54]. Used as co-medication to Western 
antipsychotic drugs such as quetiapine, clozapine, and 
olanzapine, in the case of Bupleuri radix it is known 
that this is associated with nearly 60% of the risk of 
adverse outcomes[4,12,55]. Other potential risk factors for 
liver injury by TCM herbs may include higher dosages 
and lipophilicity of chemicals and known conditions 
from DILI cases[56]. Publications on the quality problems 
of some herbal TCM products[20-24] called for providing 
excellent quality for our patients as high priority, which 
is a strength of this study and avoids discussions around 
product quality as causative for the observed liver injury. 
In the present study, Bupleuri radix and Scutellariae 
radix are the two TCM herbs most implicated in liver 
injury (Tables 3-5). However, both herbs turned out 
to be the most frequently prescribed drugs in the TCM 
hospital in Bad Kötzting in general[57]. Even though liver 
injury from Polygonum multiflorum has increasingly 
been reported in recent years[9-11], but convincing 
evidence for causality is limited in the present analysis 
(Tables 3-5). Previous regulatory discussions focused 
on herbal products containing unsaturated pyrrolizidine 
alkaloids (PAs), and in 2012, EMA stated that herbal 
medicinal products containing herbal preparations with 
toxic, unsaturated PAs (even in very low amounts) 
should not be used orally[58]. Used in high amounts 
for a prolonged period, PAs can cause HSOS (hepatic 
sinusoidal obstruction syndrome)[19]. TCM herbs also 
include Jue Ming Zi (Cassia), but only its leaves and 
fruits contain PAs and may cause HSOS[19,58]. Cassiae 
semen lacks PAs that has been used by two patients, 
who as expected had no signs of HSOS (Table 5).
The use of herbal TCM is widely considered less 
risky as compared with synthetic drugs, although data 
on direct comparisons are not available in support of 
this view. Populations using herbal TCM, drugs, either 
alone, or combined experience more DILI than HILI, 
possibly due to a higher use of drugs[27]. Valid data 
of incidence and prevalence of HILI caused by TCM 
herbs are lacking[19], and respective data cannot be 
derived from the present study with a low frequency 
of liver injury of 0.12% among all 21470 patients 
treated with herbal TCM. Valid data were published for 
drugs, showing that idiosyncratic DILI is a rare event, 
in a population-based French study with an annual 
estimated incidence of 13.9 ± 2.4 cases per 100000 
inhabitants[53]. A good overview of suspicious TCM 
herbs is provided in several reports[2,13-15,34], which were 
also used for comparison in our own survey (Table 5). 
Nevertheless, the list of suspected TCM herbs remains 
tentative (Tables 3-5). 
Limitations of our study: The focus of our investi-
gation was on ALT levels > 5 × ULN, considering 
thereby real HILI cases. Cases with ALT elevations 
between 2 and 5 × ULN are per definition not real 
but milder HILI due to treatment with TCM herbs, not 
requiring additional causality proof using RUCAM. As 
all patients with real HILI had a good outcome with 
ALT normalization during the relatively short follow-
up periods, this favorable outcome can be expected 
also for patients with milder HILI. A single normal 
pre-treatment ALT value likely excludes pre-existing 
liver disease, though little uncertainty remains, which 
would decrease rather than increase the overall 
frequency of HILI by TCM. By study protocol, patients 
with increased ALT values were explicitly not included, 
although it would have been of interest how TCM 
treatment influences increased pre-treatment ALT 
values. 
In this report, we present liver injury data for the 
first time derived from a prospective, hospital-based 
and large-scale study of 21470 patients, who received 
treatment with TCM herbs and had no liver disease 
before. ALT was used as a diagnostic biomarker to 
exclude liver disease prior to therapy initiation and 
to assess liver integrity during and after the therapy. 
This study of 21470 patients revealed that herbal 
TCM products cause rare liver injury in 26 patients 
corresponding to 0.12%. Liver injury rapidly improved 
in most patients following cessation of the therapy, 
also substantiating causality for the suspected TCM 
herbs. Under the present study conditions, a transition 
of acute liver injury to a chronic course was not ob-
served. As these encouraging results are based on 
strict protocol in a hospital setting, it remains to be 
established whether these data can be transferred 
to normal field conditions. Indeed, in the real world 
confounding variables prevail, such as pre-existing 
chronic liver diseases, complex therapy conditions 
of co-medication with Western drugs, and possible 
problems of herbal TCM product quality regarding 
misidentification of herbs, impurities of heavy metals, 
pesticides and other toxins, and adulteration by 
Western drugs to enhance efficacy. To be on the side 
of caution and for risk minimizing physicians are well 
advised to inform patients about the low risk and 
symptoms of liver injury associated with the use of 
TCM herbs, if patients decide on this special therapy 
option.
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they are of natural origin, and mainly based the belief of their efficiency and 
lack of adverse events, and their preference as valuable alternatives over a 
conventional treatment with synthetic drugs. However, some criticism emerged 
regarding the issue of efficiency, and adverse reactions ranging from clinically 
not relevant events to more severe ones including suspected liver injury. 
Research frontiers
In a prospective, hospital-based study, patients with normal values of alanine 
aminotransferase (ALT) as a diagnostic marker for ruling out pre-existing liver 
disease were enrolled and reassessed on discharge by routine laboratory within 
a safety program carried out at the First German Hospital of TCM from 1994 to 
2015. Liver injury was detected in 26/21470, patients (0.12%) with normal liver 
tests prior to treatment initiation. In most of the liver injury cases, the Roussel 
Uclaf Causality Assessment Method (RUCAM)-based causality for herbal TCM 
was graded as “possible”. 
Innovations and breakthroughs
In this report, the authors present for the first time liver injury data derived from 
a prospective, hospital based and large-scale study of 21470 patients, who 
received treatment with TCM herbs and had no liver disease before. 
Applications
The findings in this study may help to bring more objectification into discussion 
about TCM herbs and their risks of liver injury. As long as the therapeutic 
efficacy of TCM herbs is poorly documented in the scientific literature, even 
low risk of liver injury by TCM herbs has to be communicated to all potential 
consumers and to the academic public. 
Terminology
Liver injury was defined ALT ≥ 5 × ULN = upper limit of normal as clinically 
relevant. 
Peer-review
This is an interesting and well-written study.
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